Enfuvirtide, Enfuvirtide Acetate, T-20, Pentafuside, Fuzeon, DP178, Enfuvirtide API, Enfuvirtide Peptide, Peptide
GMP FDA COA
159519-65-0
Pharmaceutical Grade
99%
Chengdu
Chengdu Shengnuo, Shengnuo Biopharm
g
2025-11-16
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Product Details
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceEnfuvirtide is an anti-HIV-1 fusion inhibitor peptide. Sequence: Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2.Research & Reference Note
Enfuvirtide, Enfuvirtide Acetate, T-20, Pentafuside, Fuzeon, DP178, Enfuvirtide API, Enfuvirtide Peptide, Peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
CertificatesBasic Info-
Product Name:
Enfuvirtide
Other Name:Enfuvirtide; T-2;Enfuvirtide Acetate (T-20);ENFUVIRTIDE(T-20)98+%;Enfurvitide(T-20);Pentafuside;Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH{2};Enfuvirtide;Aids059486
CAS No.:159519-65-0
Molecular Formula:C204H301N51O64
Molecular Weight:4491.92
Exact Mass:4489.19000
EC Number:1533716-785-6
Categories:
Characteristics-
PSA:
1902.89000
XLogP3:5.69700
Appearance:white to off-white
Density:1.59g/cm3
Storage Conditions:-20°C
Hazard IdentificationClassification of the substance or mixture
Skin sensitization, Category 1
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H317 May cause an allergic skin reaction
Precautionary statement(s) Prevention P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P272 Contaminated work clothing should not be allowed out of the workplace.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P333+P317 If skin irritation or rash occurs: Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Location:
Chengdu Shengnuo Biopharm Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
365 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Retatrutide, LY3437943, Retatrutide API, Retatrutide Peptide, Peptide, GLP-1
Pharmaceutical Grade / 99%
-
-
-
-
Matrixyl
kg / 99%
-
-
-
-
Exenatide, GLP-1, Exendin-4, Exenatide Acetate Salt, Exenatide API, Exenatide Peptide, Peptide
Pharmaceutical Grade / 99%
-